Beta Bionics (BBNX) Short-term Investments (2023 - 2026)

Beta Bionics has disclosed Short-term Investments across 4 years of filings, most recently posting $136.2 million for Q2 2026.

• In Q2 2026, Short-term Investments fell 36.56% year-over-year to $136.2 million; the TTM figure through Jun 2026 stood at $136.2 million (down 36.56% YoY), while the FY2025 annual figure was $187.5 million, up 156.41% from the prior year.
• Short-term Investments came in at $136.2 million for Q2 2026 at Beta Bionics, down from $169.3 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $214.6 million in Q2 2025 to a low of $70.2 million in Q4 2023.
• Average Short-term Investments over 4 years is $153.8 million, with a median of $178.4 million recorded in 2025.
• Year-over-year, Short-term Investments jumped 156.41% in 2025 and tumbled 36.56% in 2026.
• Over 4 years, Short-term Investments stood at $70.2 million in 2023, then increased by 4.22% to $73.1 million in 2024, then jumped by 156.41% to $187.5 million in 2025, then declined by 27.39% to $136.2 million in 2026.
• Per Business Quant data, the three most recent Short-term Investments figures were $136.2 million in Q2 2026, $169.3 million in Q1 2026, and $187.5 million in Q4 2025.